Ensysce Biosciences Inc - PF614-201 Clinical Study Results Expected By End Of Year
Portfolio Pulse from Benzinga Newsdesk
Ensysce Biosciences Inc. is expected to release the clinical study results of PF614-201 by the end of the year.
November 09, 2023 | 10:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The upcoming release of clinical study results for PF614-201 could potentially impact the stock price of Ensysce Biosciences Inc.
The release of clinical study results often impacts a biotech company's stock price. Positive results could lead to an increase in stock price, while negative results could lead to a decrease. As the results are not yet known, the impact is currently neutral.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100